Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
1.810
+0.020 (1.12%)
Jun 27, 2025, 4:00 PM - Market closed
Galmed Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 4.77 | 4.65 | 2.86 | 2.02 | 2.88 | 6.95 | Upgrade
|
| Short-Term Investments | 10.96 | 10.68 | 9.78 | 11.77 | 31.93 | 43.94 | Upgrade
|
| Cash & Short-Term Investments | 15.73 | 15.33 | 12.64 | 13.79 | 34.82 | 50.89 | Upgrade
|
| Cash Growth | 45.49% | 21.27% | -8.29% | -60.41% | -31.58% | -32.59% | Upgrade
|
| Other Receivables | 0.45 | 0.21 | 0.17 | 0.16 | 0.08 | 0.07 | Upgrade
|
| Receivables | 0.45 | 0.21 | 0.17 | 0.16 | 0.08 | 0.07 | Upgrade
|
| Prepaid Expenses | - | 0.46 | 0.32 | 0.67 | 1.05 | 0.75 | Upgrade
|
| Restricted Cash | 0.12 | 0.12 | 0.12 | 0.11 | 0.11 | 0.11 | Upgrade
|
| Total Current Assets | 16.3 | 16.12 | 13.24 | 14.72 | 36.05 | 51.81 | Upgrade
|
| Property, Plant & Equipment | - | - | 0.13 | 0.34 | 0.55 | 0.57 | Upgrade
|
| Long-Term Investments | 2.12 | 2.12 | 3.27 | 1.5 | - | - | Upgrade
|
| Total Assets | 18.68 | 18.5 | 16.63 | 16.56 | 36.61 | 52.38 | Upgrade
|
| Accounts Payable | 1.31 | 1.31 | 1.88 | 2.56 | 4.87 | 7.05 | Upgrade
|
| Accrued Expenses | - | 0.86 | 0.83 | - | - | - | Upgrade
|
| Current Portion of Leases | - | - | 0.04 | 0.17 | 0.21 | 0.2 | Upgrade
|
| Other Current Liabilities | 0.5 | 0.01 | - | 0.36 | 0.8 | 0.76 | Upgrade
|
| Total Current Liabilities | 1.81 | 2.17 | 2.75 | 3.09 | 5.88 | 8.01 | Upgrade
|
| Long-Term Leases | - | - | - | 0.04 | 0.23 | 0.22 | Upgrade
|
| Total Liabilities | 1.81 | 2.17 | 2.75 | 3.14 | 6.11 | 8.23 | Upgrade
|
| Common Stock | 1.03 | 0.74 | 0.21 | 0.07 | 0.07 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 217.82 | 216.47 | 207.08 | 200.14 | 198.77 | 179.53 | Upgrade
|
| Retained Earnings | -201.57 | -200.47 | -192.95 | -186.04 | -168.17 | -135.71 | Upgrade
|
| Comprehensive Income & Other | -0.4 | -0.42 | -0.45 | -0.75 | -0.17 | 0.27 | Upgrade
|
| Shareholders' Equity | 16.88 | 16.33 | 13.88 | 13.42 | 30.5 | 44.15 | Upgrade
|
| Total Liabilities & Equity | 18.68 | 18.5 | 16.63 | 16.56 | 36.61 | 52.38 | Upgrade
|
| Total Debt | - | - | 0.04 | 0.22 | 0.44 | 0.42 | Upgrade
|
| Net Cash (Debt) | 15.73 | 15.33 | 12.6 | 13.57 | 34.38 | 50.47 | Upgrade
|
| Net Cash Growth | 45.49% | 21.66% | -7.13% | -60.53% | -31.88% | -32.84% | Upgrade
|
| Net Cash Per Share | 12.85 | 16.47 | 54.60 | 97.14 | 251.58 | 426.87 | Upgrade
|
| Filing Date Shares Outstanding | 2.26 | 2.26 | 0.5 | 0.14 | 0.14 | 0.14 | Upgrade
|
| Total Common Shares Outstanding | 2.26 | 1.66 | 0.42 | 0.14 | 0.14 | 0.12 | Upgrade
|
| Working Capital | 14.49 | 13.95 | 10.49 | 11.63 | 30.18 | 43.8 | Upgrade
|
| Book Value Per Share | 7.47 | 9.81 | 33.01 | 95.87 | 218.80 | 372.67 | Upgrade
|
| Tangible Book Value | 16.88 | 16.33 | 13.88 | 13.42 | 30.5 | 44.15 | Upgrade
|
| Tangible Book Value Per Share | 7.47 | 9.81 | 33.01 | 95.87 | 218.80 | 372.67 | Upgrade
|
| Machinery | - | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | Upgrade
|
| Leasehold Improvements | - | 0.24 | 0.24 | 0.24 | 0.23 | 0.22 | Upgrade
|
Updated May 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.